Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

0.64
Delayed Data
As of Apr 29
 0.00 / 0.00%
Today’s Change
0.22
Today|||52-Week Range
2.00
-8.57%
Year-to-Date
No recent news for Alexza Pharmaceuticals Inc.

Today’s Trading

Previous close0.64
Today’s open0.65
Day’s range0.58 - 0.65
Volume67,879
Average volume (3 months)169,444
Market cap$13.9M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+47.83%
Earnings growth (this year)-8.33%
Earnings growth (next 5 years)--
Revenue growth (last year)-9.62%
P/E ratioNM
Price/Sales2.76
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ECTEEcho Therapeutics In...+0.02+1.59%
NBYNovaBay Pharmaceutic...+0.41+15.01%
RTTRRitter Pharmaceutica...+0.02+1.24%
NEOTNeothetics Inc-0.13-12.80%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 12, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$5.0M
Annual profit (last year)-$21.3M
Net profit margin-424.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Thomas Braxton King
Vice President-
Operations
Catherine McAuliffe
Corporate headquarters
Mountain View, California

Forecasts

Partner Offers

Search for Jobs